CreditReports.dk
HomeScreen companies

BIOFAC A/S Financials, key figures and credit report

CVR number: 62550511 Established 1934 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Englandsvej 350-356, 2770 Kastrup tel: 70103020
Gross profit 73 647.4 kDKK FY 2024 +12.2% vs 2023
EBIT - 436.1 kDKK FY 2024 -108.4% vs 2023
Net debt 110 868.3 kDKK FY 2024 -6% vs 2023
Quick ratio 0.8 FY 2024 -0.1 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit28 824.1620 289.4063 284.4165 634.7973 647.43
Employee benefit expenses-24 583.78-23 491.91-53 251.64-56 950.07-60 812.76
Total depreciation-3 874.51-3 076.26-3 567.77-3 504.58-13 270.74
EBIT365.88-6 278.776 465.005 180.15- 436.07
Other financial income1 461.011 965.831 716.842 296.172 306.25
Other financial expenses-3 244.86-3 290.81-6 118.49-7 045.97-6 492.77
Pre-tax profit-1 417.97-7 603.752 063.34430.35-4 622.59
Income taxes282.831 651.05- 453.74-97.83846.70
Net earnings-1 135.15-5 952.701 609.61332.52-3 775.89

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Land and waters1 445.751 361.881 304.381 246.731 189.23
Buildings21 371.1421 659.7318 823.2015 887.8113 972.95
Machinery and equipment172.6082.5437.68145.73152.18
Tangible assets total22 989.4923 104.1520 165.2617 280.2715 314.37
Investments total
Long term receivables total
Semifinished products14 777.397 591.2712 220.4011 173.01
Raw materials and consumables10 592.3210 898.5313 338.1914 227.57
Finished products/goods5 002.3927 723.083 872.301 682.695 261.02
Inventories total30 372.1127 723.0822 362.0927 241.2830 661.60
Current trade debtors15 404.3025 587.2835 761.0428 215.8323 355.67
Current amounts owed by group member comp.77 141.4149 530.1365 471.0872 623.0475 255.53
Prepayments and accrued income988.69702.83690.151 946.991 778.09
Current other receivables13 035.0113 373.5412 274.1013 046.533 428.08
Current deferred tax assets1 508.27417.921 114.09
Short term receivables total108 077.7089 611.70114 196.37115 832.39104 931.46
Cash and bank deposits52.142 127.4211.91977.53248.82
Cash and cash equivalents52.142 127.4211.91977.53248.82
Balance sheet total (assets)161 491.43142 566.35156 735.63161 331.47151 156.25

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital1 000.001 000.001 000.001 000.001 000.00
Retained earnings18 731.9917 596.8411 644.1513 253.7513 586.27
Profit of the financial year-1 135.15-5 952.701 609.61332.52-3 775.89
Shareholders equity total18 596.8412 644.1514 253.7514 586.2710 810.38
Provisions5 546.584 313.444 696.654 726.923 449.09
Non-current loans from credit institutions80.24
Non-current liabilities total80.24
Current loans from credit institutions112 578.7396 855.40100 320.3298 634.29100 178.15
Advances received614.83
Current trade creditors8 671.6718 594.9013 325.3914 239.7115 992.70
Current owed to group member16 136.6520 339.6610 938.96
Short-term deferred tax liabilities70.53138.09
Other non-interest bearing current liabilities16 017.3710 158.467 932.348 666.529 172.14
Current liabilities total137 267.77125 608.76137 785.23142 018.28136 896.78
Balance sheet total (liabilities)161 491.43142 566.35156 735.63161 331.47151 156.25
Page generated